Annual report [Section 13 and 15(d), not S-K Item 405]

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)

v3.25.1
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
SCHEDULE OF FAIR VALUE, LIABILITIES MEASURED ON RECURRING BASIS

As of December 31, 2023, we had contingent consideration that is required to be measured at fair value on a recurring basis.

 

Our financial instruments measured at fair value on a recurring basis were as follows at the dates indicated:

 

(in thousands)   Caption   Level 1     Level 2     Level 3     Total  
   

Consolidated

Balance Sheet

  Fair Value at December 31, 2023  
(in thousands)   Caption   Level 1     Level 2     Level 3     Total  
Liabilities:                            
Contingent consideration - current   Accrued expenses and other current liabilities   $     $     $ 1,000     $ 1,000  
Total Liabilities       $     $     $ 1,000     $ 1,000  
SCHEDULE OF FAIR VALUE, LIABILITIES MEASURED ON RECURRING BASIS UNOBSERVABLE INPUT RECONCILIATION

A reconciliation of our liabilities that are measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) for the years ended December 31, 2024 and 2023 is as follows:

 

(in thousands)   Contingent Consideration  
Balance, December 31, 2022   $ 2,738  
Cash payments for earn contingent consideration     (350 )
Transfer to notes payable     (1,650 )
Loss from fair value adjustments included in results of operations     262  
Balance, December 31, 2023   $ 1,000  
Gain from fair value adjustments included in results of operations     (1,000 )
Balance, December 31, 2024   $